I don’t accept failure – I thrive on success.

In order to be successful in business, you have to surround yourself with motivated, successful people.

The best predictor of future success is proven past success. The Boresha Team personifies this.

If every scientific breakthrough that I ever invented – generated over a $ Billion dollars in sales . . . oh wait – it did.

If you want to generate a $ Billion dollars, then you need a Billion-dollar partner.

According to the United States Patent Office, the average Patent does not even generate the monies required to file the patent – 98.8 % of ALL PATENTS ARE COMPLETE FINANCIAL FAILURES.

It’s tough out there – so we need to align with success, drive, fairness, focus, and the ability to deliver State-of-the-Art science and products.

You know what I love most about science? Science loves the truth.

My science team is dedicated to the delivery of truth, which provides Boresha with the unique ability to “Stand-and-deliver the highest quality of State-of-the-Art science in the world.”

We do not take that statement lightly, which means we have the full capability of defending our position:

•	No other company has a complete line of Certified Low Glycemic products
•	No other company has products based on Brain-Glycemic-Indexing (Cephalic Response)
•	No other company has the technology to produce products that incorporate Brain-Science - “The Science of the Brain as it relates to Food Addictions”

Why is the Glycemic Index so important?

The Glycemic Index is currently the hottest topic in the field of nutrition because the Glycemic Index is the most important strategy in formulating products that address current health issues facing the global population.

In order to address the current obesity and diabetes epidemic, we must produce and make available, foods and beverages that do not imbalance blood sugar and insulin levels, and that do not stimulate fat-storage.

Low Glycemic foods, beverages, and Nutraceuticals are preferential because they:

•	Do not stimulate blood glucose imbalances
•	Do not stimulate fat-storage
•	Do not increase risk of diabetes
•	It an important tool in fighting the obesity and diabetes epidemic in adults
•	Do not contribute to the childhood obesity epidemic

The Glycemic Index has become so important, that some products are actually claiming to be “Low Glycemic” even though they have no science to back up the claims. This is really sad. The public has the right to know which products are Low Glycemic and which are not.

If you want to know the difference between a fake Low Glycemic claim, and a real Low Glycemic claim, the answer is Board Approved Human In Vivo Clinical Trials.

I received the first Low Glycemic patent ever awarded worldwide, and have been researching the glycemic index since 1983. That puts us at the forefront of understanding the Glycemic Index and the capability of producing authentic Low Glycemic products and science.

As Chief of Biomedical Research for the Glycemic Research Institute® in Washington, D.C., we conduct Board Approved Human In Vivo Clinical Trials for the largest food companies in the world.

This provides us with a very definitive understanding of how the Glycemic Index affects human health and how High Glycemic foods contributes to the obesity and diabetes epidemic.

Real science equals real products. Boresha is never going to market “fruit juice” and pretend that it’s amazing science.

Boresha is dedicated to the formula: Research & science + innovation + dedication to health solutions NECESSITY IS THE MOTHER OF INVENTION . . . and THAT MAKES BORESHA THE FATHER OF INVENTION.

Dr. Ann de Wees Allen®
Chief of Research
Medical Advisory Board
Boresha International